Article
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges | CNN Business
Rating:
0.0
Views:
74
Likes:
1
Library:
1
Teva Pharmaceuticals agreed to pay more than $200 million in fines and divest a key generic drug treating cholesterol to settle price-fixing charges from the US Department of Justice, the agency announced Monday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value